— Know what they know.
Not Investment Advice
Also trades as: 0JW9.L (LSE) · $vol 0M

LITS NASDAQ

Lite Strategy, Inc.
1W: -2.5% 1M: -14.7% 3M: +21.9% YTD: -24.7% 1Y: -40.2% 3Y: -78.7% 5Y: -97.4%
$1.16
+0.04 (+3.12%)
Pre-Market: $1.31 (+0.16, +13.42%)
Weekly Expected Move ±8.7%
$1 $1 $1 $1 $1
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 29 · $35.1M mcap · 24M float · 1.70% daily turnover · Short 30% of daily vol
Credit Risk of going bust: not rated Debt: 0.0% of company value Bonds: none of note held by US funds details ▾
Not rated: no debt. Altman Z'' 3.44.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Income Trends

Revenue
$0 +0.0% ▲
Gross Profit
$0 +100.0% ▲
Operating Income
-$12M +29.7% ▲
Net Income
-$71M -346.2% ▼
EPS (Diluted)
$-2.06 +13.8% ▲
EBITDA
-$12M +28.2% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2022FY2023FY2024FY2025FY2026
Revenue$41M$49M$65M$0$0
YoY Growth+17.0%+19.9%+33.8%-100.0%+0.0%
Cost of Revenue$0$0$0$368K$0
Gross Profit$41M$49M$65M-$368K$0
Gross Margin100.0%100.0%100.0%——
R&D Expenses$86M$52M$17M$4M$122K
SG&A Expenses$31M$33M$23M$14M$12M
Operating Expenses$116M$86M$51M$17M$12M
Operating Income-$75M-$37M$15M-$17M-$12M
Operating Margin-185.5%-75.3%22.3%——
Interest Expense$0$0$0$0$0
Income Before Tax-$54M-$32M$18M-$16M-$71M
Tax Expense$0$0$0$0$0
Net Income-$54M-$32M$18M-$16M-$71M
Net Margin-133.8%-65.2%27.2%——
EPS (Diluted)$-9.99$-4.78$2.67$-2.39$-2.06
EBITDA-$75M-$36M$26M-$17M-$12M
Shares Outstanding6M7M7M7M35M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms